Phase
Condition
Anesthesia
Treatment
Remifentanil
Dexmédétomidine 0.5 g/kg + lidocaine 1.5 mg/kg
Clinical Study ID
Ages 18-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patients having planned cardiac surgery under cardiopulmonary bypass, with at leastone coronary artery bypass grafting and rf at least one internal mammary artery asgraft; possible association with aortic valve replacement
Patient having red and understood the information letter and signed the consent form
For women : of childbearing age, need to confirm the absence of an active pregnancyby a negative blood pregnancy test within 48 hours prior to inclusion / menopausal (amenorrhea not medically induced for at least 12 months before the inclusion visit)
Patient affiliated to a social security scheme
Exclusion
Exclusion Criteria:
Preoperative treatment with morphine or its derivatives (including tramadol) in the 15 days preceding the inclusion visit
Pre-existing high-degree conduction disorder
Bradycardia < 50 bpm
Oxygen therapy prior to inclusion
Heart failure with LVEF <40%
BMI ≥ 35 kg/m²
Myocardial suffering in the 5 days preceding inclusion
Patient in shock
Known adrenal insufficiency and / or long-term systemic corticosteroid treatment (equivalent to hydrocortisone hemisuccinate ≥ 20 mg / day)
Combined surgery other than aortic valve
Long-term non-invasive ventilation (including for obstructive sleep apnea syndrome)
Any antecedent or active practice (s) of drug addiction;
Contraindication to one of the experimental and / or non-experimental treatments:dexmedetomidine, lidocaine, dexamethasone, ketamine, remifentanil or morphine
Acute cerebrovascular pathology,
Severe hepatic insufficiency (factor V level <50%),
Pre-existing cognitive disorders,
Patient for whom the CAM-ICU questionnaire cannot be carried out (deaf patients forexample),
Pregnant or parturient or breastfeeding woman
Person deprived of liberty by an administrative or judicial decision or personplaced under judicial protection / under guardianship or guardianship
Patient participating in another drug trial or having participated in another drugtrial within 1 month before randomization
Study Design
Study Description
Connect with a study center
Rouen University Hospital
Rouen, France, Normandy 76031
FranceSite Not Available
Amiens Univesrity Hospital
Amiens,
FranceSite Not Available
CAEN university Hospital
Caen,
FranceSite Not Available
Lille Hopistal University
Lille,
FranceSite Not Available
Montpellier University Hospital
Montpellier,
FranceSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.